Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer.

ABSTRACT:

Importance

Active surveillance in men with less aggressive prostate cancer is inconsistently used despite clinical guidelines. Renumeration generally favors treatment over conservative management and may contribute to the variable adoption of active surveillance, which suggests that value-based payment incentives may promote guideline-concordant care.

Objective

To describe the adoption of active surveillance in low-risk prostate cancer, following the initiation of a novel payment incentive sponsored by a commercial payer to support its use.

Design, setting, and participants

This cohort study included men with prostate cancer diagnosed between 2015 to 2021 with data registered with the Michigan Urological Surgery Improvement Collaborative (MUSIC), a statewide quality-i

SUBMITTER: Srivastava A 

PROVIDER: S-EPMC11795379 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature